Precigen Inc. [NASDAQ: PGEN] closed the trading session at $6.42 on 07/02/21. The day’s price range saw the stock hit a low of $6.27, while the highest price level was $6.54. The company report on June 11, 2021 that Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes.
– Primary analysis data presented at the Federation of Clinical Immunology Societies (FOCIS) 2021 Virtual Annual Meeting -.
– Primary endpoint assessing safety and tolerability met for both Phase 1b monotherapy and Phase 2a combination therapy portions of study -.
The stocks have a year to date performance of -37.06 percent and weekly performance of -5.87 percent. The stock has been moved at -37.06 percent over the last six months. The stock has performed -2.28 percent around the most recent 30 days and changed -16.08 percent over the most recent 3-months.
If compared to the average trading volume of 1.30M shares, PGEN reached to a volume of 636897 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Precigen Inc. [PGEN]:
Stifel have made an estimate for Precigen Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 25, 2021. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Overweight. The new note on the price target was released on February 22, 2021, representing the official price target for Precigen Inc. stock. Previously, the target price had yet another raise to $10, while B. Riley Securities analysts kept a Buy rating on PGEN stock.
The Average True Range (ATR) for Precigen Inc. is set at 0.36, with the Price to Sales ratio for PGEN stock in the period of the last 12 months amounting to 13.81. The Price to Book ratio for the last quarter was 7.13, with the Price to Cash per share for the same quarter was set at 0.50.
PGEN stock trade performance evaluation
Precigen Inc. [PGEN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.87. With this latest performance, PGEN shares dropped by -2.28% in over the last four-week period, additionally sinking by -37.06% over the last 6 months – not to mention a rise of 33.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PGEN stock in for the last two-week period is set at 43.41, with the RSI for the last a single of trading hit 41.14, and the three-weeks RSI is set at 44.46 for Precigen Inc. [PGEN]. The present Moving Average for the last 50 days of trading for this stock 6.85, while it was recorded at 6.52 for the last single week of trading, and 7.12 for the last 200 days.
Precigen Inc. [PGEN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Precigen Inc. [PGEN] shares currently have an operating margin of -83.04 and a Gross Margin at +46.20. Precigen Inc.’s Net Margin is presently recorded at -100.58.
Return on Total Capital for PGEN is now -30.11, given the latest momentum, and Return on Invested Capital for the company is -39.28. Return on Equity for this stock declined to -149.44, with Return on Assets sitting at -26.10. When it comes to the capital structure of this company, Precigen Inc. [PGEN] has a Total Debt to Total Equity ratio set at 271.36. Additionally, PGEN Total Debt to Total Capital is recorded at 73.07, with Total Debt to Total Assets ending up at 56.21. Long-Term Debt to Equity for the company is recorded at 266.87, with the Long-Term Debt to Total Capital now at 71.86.
Reflecting on the efficiency of the workforce at the company, Precigen Inc. [PGEN] managed to generate an average of -$534,912 per employee. Receivables Turnover for the company is 4.42 with a Total Asset Turnover recorded at a value of 0.26.Precigen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.30 and a Current Ratio set at 5.70.
Earnings per share (EPS) analysis for Precigen Inc. [PGEN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PGEN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Precigen Inc. go to 2.40%.
Precigen Inc. [PGEN]: Insider Ownership positions
There are presently around $912 million, or 69.40% of PGEN stock, in the hands of institutional investors. The top three institutional holders of PGEN stocks are: THIRD SECURITY, LLC with ownership of 81,760,477, which is approximately 0.02% of the company’s market cap and around 12.70% of the total institutional ownership; MILLER VALUE PARTNERS, LLC, holding 9,101,475 shares of the stock with an approximate value of $58.43 million in PGEN stocks shares; and VANGUARD GROUP INC, currently with $56.1 million in PGEN stock with ownership of nearly 23.012% of the company’s market capitalization.
Positions in Precigen Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 97 institutional holders increased their position in Precigen Inc. [NASDAQ:PGEN] by around 22,643,123 shares. Additionally, 45 investors decreased positions by around 1,775,884 shares, while 37 investors held positions by with 117,623,934 shares. The mentioned changes placed institutional holdings at 142,042,941 shares, according to the latest SEC report filing. PGEN stock had 31 new institutional investments in for a total of 2,146,087 shares, while 16 institutional investors sold positions of 583,799 shares during the same period.